Yep. If you've been following the changes at the FDA an accelerated approval definitely a possibility in this one. The FDA is to its credit trying to improve the laboured process of its approvals in novel biologics for chronic illnesses where patients face a very poor prognosis under standard of care. Far too mnay amputations globally for DFU. This one is crying for out an AA.
Ann: DFU Clinical Trial Enrolment Complete, page-7
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.010(4.00%) |
Mkt cap ! $46.70M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.0¢ | 25.5¢ | $2.249K | 8.652K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 18858 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 35853 | 1 |
View Market Depth
| Last trade - 10.12am 09/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |